Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Peter Kolchinsky, Ra Capital Buy More Achillion Pharmaceuticals at $2.48/Share

Peter Kolchinsky‘s, RA Capital Management solidified its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) even more today. This time, Ra Capital reported acquiring 1,795,000 shares of the company, raising its position to a total of around 22.3 million shares. The price paid by the fund amounts to $2.48 per share.

Peter Kolchinsky

Disclosure: none

Recommended Reading:

How The Debt Ceiling Increase Helped The Majority of Hedge Funds

Will Hedge Funds Take Over Fannie Mae and Freddie Mac?

Hedge Fund News: Larry Robbins, Alan Howard & Ken Griffin’s Bold Statement

Loading Comments...